Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: An Italian multicenter randomized trial

Martelli, M
Gherlinzoni, F
De Renzo, A
Zinzani, PL
De Vivo, A
Falini, B
Storti, S
Meloni, G
Rizzo, M
Molinari, AL
Lauria, F
Moretti, L
Lauta, VM
Mazza, P
Pescarmona, LGE
Pileri, SA
Mandelli, F
Tura, S.
CANTONETTI, MARIA

January 2003

Purpose: To evaluate the role of early intensification with high-dose therapy (HDT) and autologous s...

Posttransplant Primary Cutaneous Ki-1 (CD30)+/CD56+ Anaplastic Large Cell Lymphoma

양우익

January 2004

An anaplastic large cell lymphoma that was negative for Epstein-Barr virus and positive for Ki-1 (CD...

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

C. Tarella
M. Zanni
M. Di Nicola
C. Patti
R. Calvi
A. Pescarollo
V. Zoli
A. Fornari
D. Novero
A. Cabras
M. Stella
A. Comino
D. Remotti
M. Ponzoni
D. Caracciolo
M. Ladetto
M. Magni
L. Devizzi
R. Rosato
M. Boccadoro
M. Bregni
A. Gallamini
I. Majolino
S. Mirto
Gruppo italiano terapie innovative nei linfomi
P. Corradini
A.M. Gianni

June 2007

A prospective multicenter program was performed to evaluate the combination of rituximab and high-do...

Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation

November 2019

13Few series of adult patients with primary systemic CD30 (Ki-1)-positive anaplastic large cell lymp...

The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center

November 2019

11nonenoneFANIN, Renato; Sperotto A; Silvestri F; Cerno M; Geromin A; Stocchi R; Infanti L; PATRIARC...

Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma

November 2019

10nonenoneZAJA, Francesco; Sperotto A.; Tomadini V.; PATRIARCA, Francesca; Filì C.; Kikic F.; DAMIAN...

Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).

G., Longo
C., Fiorani
Sacchi, Stefano
V., Callea
M., Lombardo
Federico, Massimo
C., Stelitano
F., Angrilli
D., Vallisa
P. G., Gobbi
F., Ilariucci
A., Frassoldati
M., Petrini
V., Silingardi

January 1999

Background and Objective. Although in recent years anaplastic large-cell lymphoma (ALCL) has emerged...

F-MACHOP IN ADVANCED AGGRESSIVE LYMPHOMA

Cesare Guglielmi
S. Amadori
Maurizio Martelli
G. Papa
F. Mandelli

January 1992

The results of our ten years experience indicate that F-MACHOP, conceptually designed to exploit cel...

Aggressive Primary Cutaneous Anaplastic T-Cell Lymphoma Successfully Treated with Autologous Stem Cell Transplant and Brentuximab Vedotin Consolidation: Case Report and Review of the Literature

Luca Guarnera
Federico Meconi
Marco Pocci
Fabiana Esposito
Manuela Rizzo
Vito Mario Rapisarda
Annagiulia Zizzari
Cosimo Di Raimondo
Livio Pupo
Lucia Anemona
Maria Cantonetti

March 2022

Primary cutaneous CD30+ lymphoproliferative disorders include primary cutaneous anaplastic large cel...

ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS

LONGO G
PIERESCA C
AVANZINI P
IANNITTO E
DIPRISCO AU
BALDINI L
BRUGIATELLI M
CLO V
BEVINI M
FEDERICO, Massimo
SILINGARDI, Vittorio

January 1995

Between January 1988 and June 1992, 35 patients with primary anaplastic large cell lymphoma (ALCL)CD...

High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience

November 2019

5nonenoneSperotto A; ZAJA, Francesco; DAMIANI, Daniela; PATRIARCA, Francesca; FANIN, RenatoSperotto,...

Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

PILERI S
BARONI CD
MARTELLI M
FALINI B
SABATTINI E
GHERLINZONI F
AMADORI S
POGGI S
MAZZA P.
BOCCHIA, MONICA

January 1994

Sixty-nine anaplastic large cell lymphomas (ALCLs) were selected from an Italian comparative trial o...

The F-MACHOP regimen in the treatment of aggressive non-Hodgkin’s lymphomas: a single centre experience in 72 patients

November 2019

11nonenoneInfanti L; Silvestri F; FANIN, Renato; Salmaso F; ZAJA, Francesco; Barillari G; PATRIARCA,...

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma

van Imhoff, GW
van der Holt, B
MacKenzie, MA
Ossenkoppele, GJ
Wijermans, PW
Kramer, MHH
van't Veer, MB
Schouten, HC
Kooy, MV
van Oers, MHJ
Raemaekers, JMM
Sonneveld, P
Meulendijks, LAMH
Kluin, PM
Kluin-Nelemans, HC
Verdonck, LF

June 2005

The feasibility and efficacy of up- front high- dose sequential chemotherapy followed by autologous ...

Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.

March 2018

none6noNot available.noneDerenzini E, Casadei B, Broccoli A, Gandolfi L, Pellegrini C, Zinzani PL.De...

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: An Italian multicenter randomized trial

Martelli, M
Gherlinzoni, F
De Renzo, A
Zinzani, PL
De Vivo, A
Falini, B
Storti, S
Meloni, G
Rizzo, M
Molinari, AL
Lauria, F
Moretti, L
Lauta, VM
Mazza, P
Pescarmona, LGE
Pileri, SA
Mandelli, F
Tura, S.
CANTONETTI, MARIA

January 2003

Purpose: To evaluate the role of early intensification with high-dose therapy (HDT) and autologous s...

Posttransplant Primary Cutaneous Ki-1 (CD30)+/CD56+ Anaplastic Large Cell Lymphoma

양우익

January 2004

An anaplastic large cell lymphoma that was negative for Epstein-Barr virus and positive for Ki-1 (CD...

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

C. Tarella
M. Zanni
M. Di Nicola
C. Patti
R. Calvi
A. Pescarollo
V. Zoli
A. Fornari
D. Novero
A. Cabras
M. Stella
A. Comino
D. Remotti
M. Ponzoni
D. Caracciolo
M. Ladetto
M. Magni
L. Devizzi
R. Rosato
M. Boccadoro
M. Bregni
A. Gallamini
I. Majolino
S. Mirto
Gruppo italiano terapie innovative nei linfomi
P. Corradini
A.M. Gianni

June 2007

A prospective multicenter program was performed to evaluate the combination of rituximab and high-do...

Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation

November 2019

13Few series of adult patients with primary systemic CD30 (Ki-1)-positive anaplastic large cell lymp...

The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center

November 2019

11nonenoneFANIN, Renato; Sperotto A; Silvestri F; Cerno M; Geromin A; Stocchi R; Infanti L; PATRIARC...

Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma

November 2019

10nonenoneZAJA, Francesco; Sperotto A.; Tomadini V.; PATRIARCA, Francesca; Filì C.; Kikic F.; DAMIAN...

Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).

G., Longo
C., Fiorani
Sacchi, Stefano
V., Callea
M., Lombardo
Federico, Massimo
C., Stelitano
F., Angrilli
D., Vallisa
P. G., Gobbi
F., Ilariucci
A., Frassoldati
M., Petrini
V., Silingardi

January 1999

Background and Objective. Although in recent years anaplastic large-cell lymphoma (ALCL) has emerged...

F-MACHOP IN ADVANCED AGGRESSIVE LYMPHOMA

Cesare Guglielmi
S. Amadori
Maurizio Martelli
G. Papa
F. Mandelli

January 1992

The results of our ten years experience indicate that F-MACHOP, conceptually designed to exploit cel...

Aggressive Primary Cutaneous Anaplastic T-Cell Lymphoma Successfully Treated with Autologous Stem Cell Transplant and Brentuximab Vedotin Consolidation: Case Report and Review of the Literature

Luca Guarnera
Federico Meconi
Marco Pocci
Fabiana Esposito
Manuela Rizzo
Vito Mario Rapisarda
Annagiulia Zizzari
Cosimo Di Raimondo
Livio Pupo
Lucia Anemona
Maria Cantonetti

March 2022

Primary cutaneous CD30+ lymphoproliferative disorders include primary cutaneous anaplastic large cel...

ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS

LONGO G
PIERESCA C
AVANZINI P
IANNITTO E
DIPRISCO AU
BALDINI L
BRUGIATELLI M
CLO V
BEVINI M
FEDERICO, Massimo
SILINGARDI, Vittorio

January 1995

Between January 1988 and June 1992, 35 patients with primary anaplastic large cell lymphoma (ALCL)CD...

High-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's lymphoma: a single center experience

November 2019

5nonenoneSperotto A; ZAJA, Francesco; DAMIANI, Daniela; PATRIARCA, Francesca; FANIN, RenatoSperotto,...

Anaplastic large cell lymphoma (CD30+/Ki-1+): results of a prospective clinico-pathological study of 69 cases.

PILERI S
BARONI CD
MARTELLI M
FALINI B
SABATTINI E
GHERLINZONI F
AMADORI S
POGGI S
MAZZA P.
BOCCHIA, MONICA

January 1994

Sixty-nine anaplastic large cell lymphomas (ALCLs) were selected from an Italian comparative trial o...

The F-MACHOP regimen in the treatment of aggressive non-Hodgkin’s lymphomas: a single centre experience in 72 patients

November 2019

11nonenoneInfanti L; Silvestri F; FANIN, Renato; Salmaso F; ZAJA, Francesco; Barillari G; PATRIARCA,...

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma

van Imhoff, GW
van der Holt, B
MacKenzie, MA
Ossenkoppele, GJ
Wijermans, PW
Kramer, MHH
van't Veer, MB
Schouten, HC
Kooy, MV
van Oers, MHJ
Raemaekers, JMM
Sonneveld, P
Meulendijks, LAMH
Kluin, PM
Kluin-Nelemans, HC
Verdonck, LF

June 2005

The feasibility and efficacy of up- front high- dose sequential chemotherapy followed by autologous ...

Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.

March 2018

none6noNot available.noneDerenzini E, Casadei B, Broccoli A, Gandolfi L, Pellegrini C, Zinzani PL.De...

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: An Italian multicenter randomized trial

Martelli, M
Gherlinzoni, F
De Renzo, A
Zinzani, PL
De Vivo, A
Falini, B
Storti, S
Meloni, G
Rizzo, M
Molinari, AL
Lauria, F
Moretti, L
Lauta, VM
Mazza, P
Pescarmona, LGE
Pileri, SA
Mandelli, F
Tura, S.
CANTONETTI, MARIA

January 2003

Purpose: To evaluate the role of early intensification with high-dose therapy (HDT) and autologous s...

Posttransplant Primary Cutaneous Ki-1 (CD30)+/CD56+ Anaplastic Large Cell Lymphoma

양우익

January 2004

An anaplastic large cell lymphoma that was negative for Epstein-Barr virus and positive for Ki-1 (CD...

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

C. Tarella
M. Zanni
M. Di Nicola
C. Patti
R. Calvi
A. Pescarollo
V. Zoli
A. Fornari
D. Novero
A. Cabras
M. Stella
A. Comino
D. Remotti
M. Ponzoni
D. Caracciolo
M. Ladetto
M. Magni
L. Devizzi
R. Rosato
M. Boccadoro
M. Bregni
A. Gallamini
I. Majolino
S. Mirto
Gruppo italiano terapie innovative nei linfomi
P. Corradini
A.M. Gianni

June 2007

A prospective multicenter program was performed to evaluate the combination of rituximab and high-do...

Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults

Abstract

Extracted data

Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults

Abstract

Extracted data

Related items

Related items